Abstract 70P
Background
Methotrexate is an important component of acute lymphoblastic leukemia (ALL) protocols and methotrexate toxicity can at times lead to fatal complications which are unpredictable. Understanding gene polymorphisms is important as antidote to toxicity is not widely available and febrile neutropenia is deadly for patients with remote access to health care system in developing counties. This study was undertaken to analyse the toxicities in patients receiving high dose methotrexate and their association with methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms.
Methods
MTHFR gene polymorphisms (A1298C & C677T) were analysed using real time polymerase chain reaction on peripheral blood of patients with acute lymphoblastic leukemia receiving high dose methotrexate (HDMTx, methotrexate > 500 mg per square meter) and methotrexate toxicities were analysed. Statistical analysis was done by chi-square test.
Results
A total of 51patients received high dose methotrexate therapy, out of which 27 patients had MTHFR gene polymorphisms and 24 patients had no polymorphisms. Grade3 and 4 toxicities were seen in 16 of 51 patients (31%) of which 14patients (87.5%) had gene polymorphisms and 2 patients had no polymorphisms. All patients with toxicities having polymorphisms were heterozygous, A1298C in 9patients (64%), C677T in 5 patients (35%). Homozygous polymorphisms were not seen in any patient. A significant association was seen between MTHFR gene polymorphisms and methotrexate toxicity (p-value 0.000828) compared to those without polymorphisms.
Conclusions
Testing for MTHFR gene polymorphisms is important before starting high dose methotrexate as these patients need to be monitored carefully and dose adjustments need to be done to prevent morbidity and unpredictable mortality.
Editorial acknowledgement
Clinical trial identification
NA
Legal entity responsible for the study
NIMS, Hyderabad.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
94P - Harnessing circulating tumor DNA in bronchoalveolar lavage fluid for precise molecular diagnosis of NSCLC
Presenter: Frank Borm
Session: Cocktail & Poster Display session
Resources:
Abstract
95P - Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)
Presenter: Betzabel Cajiao Garcia
Session: Cocktail & Poster Display session
Resources:
Abstract
96P - Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in endometrial cancer (EC) patients
Presenter: Simona Duranti
Session: Cocktail & Poster Display session
Resources:
Abstract
97P - Prospects of liquid biopsy in determining prognosis in children with HGG and DIPG
Presenter: Olga Regentova
Session: Cocktail & Poster Display session
Resources:
Abstract
98P - Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response
Presenter: Ana Fernández
Session: Cocktail & Poster Display session
Resources:
Abstract
99P - Comprehensive genomic sequencing as an ancillary diagnostic tool for pathologists
Presenter: Dan Miller
Session: Cocktail & Poster Display session
Resources:
Abstract
100P - Standard serum biomarkers to help predict a cancer diagnosis in patients with non-specific symptoms: Data from Guy´s rapid diagnostic clinic
Presenter: Maria Monroy Iglesias
Session: Cocktail & Poster Display session
Resources:
Abstract
101P - Patient-derived organoids to optimize CDK4/6 inhibitor-based treatment selection in early breast cancer
Presenter: Carla Alves
Session: Cocktail & Poster Display session
Resources:
Abstract
102P - MicroRNAs in urine and saliva as non-invasive biomarkers of minimal residual disease in pediatric acute lymphoblastic leukemia
Presenter: Alejandra Pando-Caciano
Session: Cocktail & Poster Display session
Resources:
Abstract
103P - MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract